Using the microfluidic vasculature to selectively manipulate cancer cells and endothelium, we demonstrate that circulating breast cancer cells preferentially adhere to endothelium stimulated from the basal side with CXCL12. This evidence concerns the gene CXCL12 and breast carcinoma.